- Report
- February 2024
- 175 Pages
Global
From €5018EUR$5,000USD£4,169GBP
- Report
- September 2024
- 175 Pages
Global
From €5018EUR$5,000USD£4,169GBP
- Report
- August 2024
- 138 Pages
Global
From €4466EUR$4,450USD£3,711GBP
- Report
- September 2024
- 187 Pages
Global
From €4516EUR$4,500USD£3,753GBP
- Report
- January 2025
- 123 Pages
Global
From €3010EUR$2,999USD£2,501GBP
- Report
- January 2025
- 134 Pages
Global
From €3010EUR$2,999USD£2,501GBP
- Report
- August 2024
- 146 Pages
Global
From €3010EUR$2,999USD£2,501GBP
- Report
- August 2024
- 150 Pages
Global
From €3010EUR$2,999USD£2,501GBP
- Report
- August 2024
- 146 Pages
Global
From €3010EUR$2,999USD£2,501GBP
- Report
- August 2024
- 143 Pages
Global
From €3010EUR$2,999USD£2,501GBP
- Report
- August 2024
- 143 Pages
Global
From €3010EUR$2,999USD£2,501GBP
- Report
- July 2024
- 136 Pages
Global
From €3010EUR$2,999USD£2,501GBP
- Report
- May 2024
- 130 Pages
Global
From €6523EUR$6,499USD£5,419GBP
- Report
- May 2024
- 135 Pages
Global
From €6523EUR$6,499USD£5,419GBP
- Report
- May 2024
- 139 Pages
Global
From €6523EUR$6,499USD£5,419GBP
- Report
- May 2024
- 133 Pages
Global
From €6523EUR$6,499USD£5,419GBP
- Report
- May 2024
- 140 Pages
Global
From €6523EUR$6,499USD£5,419GBP
- Report
- May 2024
- 128 Pages
Global
From €6523EUR$6,499USD£5,419GBP
- Report
- May 2024
- 136 Pages
Global
From €6523EUR$6,499USD£5,419GBP
- Report
- May 2024
- 130 Pages
Global
From €6523EUR$6,499USD£5,419GBP
The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events.
The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more